Prostate cancer: Optimized PSA screening program developed

3 febrero 2015

As an indicator of prostate cancer, the PSA test is regarded in urology as highly controversial since it is not always unequivocal. A team of researchers has now developed a program that compensates the shortfalls of PSA screening with methods from personalized medicine. As a result, prostate cancer screening is able to reach a new level of quality.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/RuXPjN_yTrs/150203094153.htm

Volver